No Significant Cytotoxic Effect of the EZH2 Inhibitor Tazemetostat (EPZ-6438) on Pediatric Glioma Cells with Wildtype Histone 3 or Mutated Histone 3.3
Maria Wiese(University of Copenhagen), Christof M. Kramm(Universitätsmedizin Göttingen)
Cited by 57